APhA Annual Meeting and Exposition - American Pharmacists Association Annual Meeting and Exposition

Currently, APHA has a policy on its books that opposes both drug legalization and decriminalization.

The pandemic was eye-opening for many pharmacists, and one expert reflects on recognizing the importance of the pharmacy technician and accessible healthcare.

Akram Hussein, PharmD, MBA, BCNP, discusses the treatment process when treating a patient with prostate cancer with a radiopharmaceutical.

More and more data, both from real world analyses and clinical trials, are shedding light on the effective uses of cannabis, as well as the contraindications for its use in patients.

Even the terms themselves, “sex” and “gender,” are often misused and misunderstood by US society and medical professionals alike.

An expert suggests that education and agency are significant barriers to care in marginalized communities, which she discusses live with Pharmacy Times at the American Pharmacists Association (APhA) Meeting & Exposition in Phoenix, Arizona from March 24 to 27.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, discusses some of the ways that social determinants of health can impact patient health outcomes.

Expert weighs the benefits and pitfalls of social media, the importance of quality information from credible journal sources, and why information that sparks an emotional response can be more influential than evidence-based facts.

Although attention-deficit/hyperactivity disorder (ADHD) is not as common in adults, it can still be present and bothersome, however, adults with ADHD may have learned to hide it a bit better than children.

Prior to the pandemic, the seasonality of respiratory syncytial virus followed a pattern; now, this pattern of disease spread has changed significantly.

Vibhuti Arya, PharmD, MPH, FAPhA, explains how APhA as an organization is opening discourse among its members regarding unpacking and dismantling structural racism in the organization and in the profession at large.

Vibhuti Arya, PharmD, MPH, FAPhA, discusses the role of the individual in progressing structural and systemic changes in the pharmacy ecosystem.

Specifically, non-opioids are often preferred for the management of subacute and chronic pain because of their safety profiles.

Pharmacy Times is covering the American Pharmacists Association (APhA) Annual Meeting & Exposition in Phoenix, Arizona from March 24 to 27, 2023.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, discusses current outlook on the occurrence of outbreaks of vaccine-preventable diseases in the country.

Specifically, 3 new drugs for sickle cell disease are providing options for patients who are not responding to hydroxyurea.

Darren Mensch, PharmD, BCPS, BCACP, clinical ambulatory care pharmacist of population health at Jefferson Health in Abington, describes the role pharmacists play in team-based care, population health management, and value-based care.

Just culture framework helps to balance safety and accountability in medication error by identifying the root cause without blaming an individual.

Factors such as economic stability and education access can be categorized into social determinants of health.

Pharmacy Times spoke with Meagen Rosenthal, PhD, about her session at the APhA 2022 Annual Meeting and Exposition, titled "Heal Thyself: Burnout Recovery for Front-Line Heroes."

Pharmacy leadership remaining mindful, connected, and engaged is crucial to support the mental health needs of their staff.

Jeffery Goad, PharmD, MPH, associate dean of Academic Affairs in School of Pharmacy at Chapman University discusses the future of pharmacy when it comes to immunizations.

Daniel Krinsky, MS, owner and president of EduCare4U and PGx101, and Stefanie Ferreri, PharmD, Smith and Olsen Distinguished professor at the Eshelman School of Pharmacy in the University of North Carolina, discuss the additions, removals, and changed to OTC products in the past 2 years.

Opening the door for communication in a nonjudgmental manner is essential for pharmacists to counsel patients on cannabis use.

Pharmacy Times spoke to Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES, about her session she presented at the APhA 2022 Annual Meeting and Exposition, titled "Know the Facts: Annual Diabetes Update."

Session at the American Pharmacists Association Annual Meeting discusses the importance of naloxone in reducing the burden of the opioid epidemic.

Lisa Cordes, PharmD, BCACP, BCOP, oncology clinical pharmacy specialist at the National Institutes of Health, discusses treatment options and telehealth for prostate cancer care.

Andrew Bzowyckyi, PharmD, BCPS, CDCES, associate professor at Pacific University Oregon and clinic pharmacist at Legacy Medical Group discusses the differences in GLP-1 receptor agonists and insulin for the management of diabetes.

Melissa Somma McGivney, PharmD, FCCP, FAPhA, professor and associate dean for community partnerships at the University of Pittsburgh School of Pharmacy, gives a brief overview of the best practices when it comes to billing in a pharmacy.

A presentation at the American Pharmacists Association Annual Meeting 2022, highlighted potential innovations for community pharmacies.